Ametek 10-Qquarter ended 2026-06-30

Executive Summary

AMETEK’s Q2 growth was predominantly organic, with orders outpacing sales and backlog expanding, supporting continued demand beyond the quarter. Record earnings accompanied that growth, but acquisition costs compressed Electronic Instruments margins, while Electromechanical delivered substantial margin expansion. Cash generation supported acquisitions and debt reduction ahead of the proposed ≈$5.0B Indicor transaction, which would materially expand the business and its financing requirements. The investment thesis now rests on converting backlog profitably while integrating acquisitions without sacrificing cash conversion.

Key Financial Highlights

• Growth composition: Q2 organic growth of 10% exceeded H1’s 8%; acquisitions contributed 5% in both periods, indicating improving underlying demand rather than solely purchased growth.
• Earnings quality: Q2 acquisition-related costs included $16.2M in cost of sales and $10.0M in financing fees. Interest expense increased to $30.1M from $16.9M, while the effective tax rate declined to 17.4% from 19.0%.
• Cash conversion: H1 OCF exceeded net income by $129M; capital expenditures consumed $57.5M. FCF exceeded $424M of acquisition cash spending and $184M of combined dividends and repurchases.
• Capital structure and returns: Total debt, net fell to $2.04B from $2.28B; net debt declined to $1.54B from $1.83B. Repurchases were $28.1M against $23.6M of stock-based compensation; H1 weighted-average diluted shares declined 0.7%, a measure distinct from period-end net share reduction.

Business Developments

The proposed ≈$5.0B cash acquisition of Indicor’s instrumentation businesses, with ≈$1.1B of annual sales, is AMETEK’s principal strategic commitment. Management expects closing in H2 2026, subject to approvals. Financing preparations expanded the revolver to $3.5B and established up to $4.0B of acquisition-contingent term loans; neither facility was drawn at quarter-end.

Completed acquisitions of LKC Technologies and First Aviation Services cost $436M, adding ophthalmic diagnostics and aviation and defense services. Their current-period earnings contribution was immaterial; $400M of the purchase price represented goodwill and other intangibles.

Operating performance diverged: Electromechanical’s margin expanded to 26.2% from 23.3%, while Electronic Instruments fell to 28.0% from 29.7%, reflecting acquisition dilution and $15.0M of integration costs.

Risk Assessment

• Acquisition execution: Indicor’s ≈$5.0B price makes closing and integration consequential; existing integration costs show that purchased growth can pressure reported margins.
• Financing burden: Acquisition financing could reverse current deleveraging, while goodwill and other intangibles of $11.6B leave negative tangible common equity and increase sensitivity to acquisition underperformance.
• Trade disruption: Tariffs had no material H1 impact, but AMETEK’s international sales exposure and raw-material requirements leave demand and costs vulnerable; management is using pricing, sourcing changes and localized production to mitigate this.

No risk-factor section was found in this 10-Q. A 10-Q does not have to restate the risk factors in the annual report. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is combining organic expansion with acquisition-led diversification. The opportunity is to convert stronger demand into profitable growth while adding specialized instrumentation businesses; the threat is that financing and integration costs absorb those gains.

• Demand conversion: Q2 orders rose 28% to $2.28B, and backlog reached $4.11B. Subsequent sales growth would validate conversion; slowing sales alongside persistent backlog would weaken that signal.
• Indicor execution: Track the ≈$5.0B transaction against management’s H2 2026 closing expectation, then acquired-business growth and integration costs; delays or impairments would challenge the acquisition thesis.
• Electronic Instruments recovery: Its 28.0% margin is the starting point. Recovery alongside revenue growth would support successful integration; continuing dilution would undermine it.
• Cash and leverage: H1 FCF of $878M and net debt of $1.54B establish the pre-Indicor baseline. Sustained cash conversion and eventual debt reduction would support financing capacity; persistent debt accumulation would weaken it.

Not present in this filing: Item 3, Quantitative and Qualitative Disclosures About Market Risk; Part II Item 1A, Risk Factors.